Objective Our objective was to explore the workforce and clinical care of first and second-
trimester surgical abortion (FTSA, STSA) providers following the publication of the updated …

Objective To evaluate practices among first-trimester surgical abortion facilities and
providers in Canada in 2012 and examine the characteristics of the surgical abortion work …

Objective To understand the current availability and practice of first-trimester medical
abortion (MA) in Canada. Design Using public sources and professional networks, abortion …

Methods: We conducted a cross-sectional survey to assess facility and provider
demographics and techniques for second-trimester abortions performed in 2012. We …

Context: Recently, updated Canadian surgical and medical abortion practice guidelines
were released, mifepristone was approved by Health Canada for first trimester medical …

Background: Since 2016, abortion care has undergone several important changes,
particularly related to the provision of medical abortion using mifepristone. We aimed to …

Objective To assess whether second-trimester surgical abortion practices of US providers
agree with evidence-based policy guidelines. Study Design We conducted a cross-sectional …

Objectives Mifepristone became available in Canada in 2017. Updated national guidelines
recommend its off-label use for second/third-trimester medical abortion (STMA/TTMA) by …

Objectives To assess whether first-trimester aspiration abortion practices of US providers
agree with evidence-based policy guidelines. Study design We sent surveys by mail or …

Objectives: A 2008–2009 national survey estimated that 14% of obstetrician–gynecologists
provided abortion care. We aimed to update this estimate and document barriers to …